IL-23 receptor signaling licenses group 3-like innate lymphoid cells to restrict a live-attenuated oral Chlamydia vaccine in the gut
Infection and Immunity, Ahead of Print.
Source: Infection and Immunity - Category: Infectious Diseases Authors: Ying HeYihui WangRongze HeAhmed Mohamed AbdelsalamGuangming Zhong1Department of Microbiology, Immunology and Molecular Genetics, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA2Guangdong Provincial Key Laboratory of Gastr Source Type: research
More News: Allergy & Immunology | Chlamydia | Gastroenterology | Genetics | Infectious Diseases | Laboratory Medicine | Microbiology | Science | Texas University | Vaccines